Other defining parameters such as molecular data, i.e., the identification of the PML::RARA transcript, usually fall into a 3-day turnaround window, hence the need for MFC analysis to confirm an APL diagnosis sooner. This evidence concerns the gene PML and acute promyelocytic leukemia.